drugset / Trial / NCT03458117
T-VEC in Non-melanoma Skin Cancer
NaSingle-groupOpen-labelTreatment
Summary
Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) in patients with locally advanced non-melanoma skin cancer.
Timeline
- Start
- 2018-04-19
- Primary completion
- 2022-02-04
- Completion
- 2022-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talimogene Laherparepvec | Other / unclassified | 4 ml | Other |